Key result
Acute hyperglycemia for 4 hours did not inhibit insulin's ability to increase skeletal muscle microvascular perfusion but provoked a slight increase in aortic stiffness.
Why the study?
Clinical data were lacking on how acutely the vasculature responds to hyperglycemia, and whether dynamic effects of acute hyperglycemia influence insulin-mediated micro- and macrovascular function.
Does acute hyperglycemia inhibit insulin's effects on microvascular perfusion in healthy young adults?
RCT
crossover
Does acute hyperglycemia inhibit insulin's effects on microvascular perfusion in healthy young adults?
Acute hyperglycemia for 4 hours does not inhibit insulin's ability to increase skeletal muscle microvascular perfusion in healthy humans, though it may provoke a slight increase in aortic stiffness.
Answers are grounded in this paper and cite their sources.
Acute hyperglycemia does not blunt insulin-mediated microvascular perfusion; leaves open whether this holds in diabetes or with prolonged exposure.
Diabetes mellitus accelerates vascular disease through multiple biochemical pathways driven by hyperglycemia, with insulin resistance and/or hyperinsulinemia also contributing. Persons with diabetes mellitus experience premature large vessel and microvascular disease when compared to normoglycemic controls. Currently there is a paucity of clinical data identifying how acutely the vasculature responds to hyperglycemia and whether other physiologic factors (e.g., vasoactive hormones) contribute. To our knowledge, no prior studies have examined the dynamic effects of acute hyperglycemia on insulin-mediated actions on both micro- and macrovascular function in the same subjects. In this randomized crossover trial, healthy young adults underwent two infusion protocols designed to compare the effects of insulin infusion during euglycemia and hyperglycemia on micro- and macrovascular function. Both euglycemic- and hyperglycemic-hyperinsulinemia increased skeletal (but not cardiac) muscle microvascular blood volume (each p<0.02) and blood flow significantly (each p<0.04), and these increases did not differ between protocols. Hyperglycemic-hyperinsulinemia trended towards increased carotid-femoral pulse wave velocity (indicating increased aortic stiffness; p= 0.065 after Bonferroni adjustment), while euglycemic-hyperinsulinemia did not. There were no changes in post-ischemic flow velocity or brachial artery flow-mediated dilation during either protocol. Plasma endothelin-1 levels significantly decreased during both protocols (each p<0.02). In this study, acute hyperglycemia for 4 hours did not inhibit insulin's ability to increase skeletal muscle microvascular perfusion but did provoke a slight increase in aortic stiffness. Hyperglycemia also did not adversely affect myocardial microvascular perfusion or endothelial function or prevent the decline of endothelin-1 during insulin infusion.
No takes yet. Share an insight, caveat, or question.
Horton et al. (2020) conducted an RCT in Healthy. Hyperglycemic-hyperinsulinemia vs. Euglycemic-hyperinsulinemia was evaluated on Skeletal muscle microvascular blood volume and blood flow. Acute hyperglycemia for 4 hours did not inhibit insulin's ability to increase skeletal muscle microvascular perfusion but provoked a slight increase in aortic stiffness.
Synapse has enriched 10 related papers. Consider them for comparative context: